Emil J. Freireich
埃米尔·弗雷瑞克
MD
Professor Emeritus (Legacy)名誉教授(历史)
👥Biography 个人简介
Emil Freireich was a revolutionary oncologist who pioneered combination chemotherapy protocols that first achieved remissions and eventual cures in childhood acute lymphoblastic leukemia. Working with Emil Frei III and James Holland at the National Cancer Institute in the late 1950s and 1960s, Freireich developed the VAMP (vincristine, amethopterin, 6-mercaptopurine, prednisone) combination regimen that produced complete remissions in ALL. His persistence against strong institutional skepticism, his advocacy for aggressive treatment of pediatric cancer, and his invention of platelet transfusions to manage treatment-associated bleeding collectively transformed childhood leukemia from universally fatal to potentially curable. His insistence that combination chemotherapy could cure cancer was prescient and foundational.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
VAMP Combination Chemotherapy in ALL
Developed and championed VAMP and related combination chemotherapy regimens for childhood ALL at NCI, achieving the first durable complete remissions and establishing the principle that combination chemotherapy could cure human cancer.
Platelet Transfusion Innovation
Invented the concept and technique of platelet transfusions to manage chemotherapy-induced thrombocytopenia and prevent fatal hemorrhage, enabling dose-intensive chemotherapy administration that would otherwise be impossible.
Representative Works 代表性著作
The Effect of 6-Mercaptopurine on the Duration of Steroid-Induced Remissions in Acute Leukemia
Blood (1963)
Combination chemotherapy extending remissions in childhood leukemia.
Platelet Transfusions as Therapy for Thrombocytopenia
Cancer Research (1963)
Introduction of platelet transfusions enabling dose-intensive chemotherapy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 埃米尔·弗雷瑞克 的研究动态
Follow Emil J. Freireich's research updates
留下邮箱,当我们发布与 Emil J. Freireich(University of Texas MD Anderson Cancer Center (Legacy, 1927-2021))相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment